Merck

An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Photo: Reuters
Coronavirus chronicle

Merck's Covid-19 pill active against Omicron in lab studies

Pfizer said in December lab data suggested  its drug Paxlovid retained its effectiveness against Omicron

Boxes containing the Pfizer-BioNTech Covid-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Michigan, US, December 13, 2020. Morry Gash/Pool via REUTERS/File Photo
Coronavirus chronicle

US FDA set to authorise Pfizer, Merck Covid-19 pills this week

Photo :Collected
Coronavirus chronicle

US panel backs first-of-a-kind Covid-19 pill from Merck

In this undated file image provided by Merck & Co. shows their new antiviral medication. The pharmaceutical Merck has agreed to allow other drugmakers worldwide to make its Covid-19 treatment, the first pill that has been shown to be effective against the disease, in a move aimed at helping millions of people in poorer countries access to the drug. In a statement on Wednesday, Oct. 27, 2021, the UN-backed Medicines Patent Pool said it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. (Merck & Co. via AP, File)
Covid-19 in Bangladesh

Merck agrees to let other drug makers make its Covid pill

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Merck Covid-19 pill sparks calls for access for lower income countries

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Merck seeks first US FDA authorisation for Covid-19 tablet

Family doctor Vera Maria Soditt vaccinates a patient at her home with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine in Cologne, Germany, March 28, 2021. REUTERS/Thilo Schmuelgen
Coronavirus chronicle

Germany still working on recommendation for Covid-19 booster shot

An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Photo: Reuters
Coronavirus chronicle

Australia to buy Merck's Covid-19 pill, Victoria cases hit record

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, US, July 12, 2018. Photo: Reuters
Coronavirus chronicle

Merck says research shows its Covid-19 pill works against variants

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo
Coronavirus chronicle

Merck begins late-stage trial of experimental Covid-19 drug

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

India's Hetero seeks emergency use nod for Merck's Covid-19 drug

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, US, July 12, 2018. REUTERS/Brendan McDermid
Coronavirus chronicle

Five Indian drugmakers to jointly start local trial of Merck & Co's Covid-19 drug

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo
Coronavirus chronicle

US to buy about 1.7 mln courses of Merck's Covid-19 treatment for $1.2 bln